Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS - Narrative (Details)

v3.23.1
INVESTMENTS - Narrative (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Dec. 21, 2018
EUR (€)
Apr. 30, 2022
USD ($)
shares
Apr. 30, 2022
EUR (€)
shares
Dec. 31, 2020
USD ($)
Jan. 31, 2019
EUR (€)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2020
USD ($)
Mar. 27, 2023
$ / shares
Dec. 31, 2022
USD ($)
Dec. 31, 2020
€ / shares
Dec. 01, 2020
Nov. 30, 2020
Sep. 30, 2020
EUR (€)
Sep. 30, 2019
USD ($)
shares
Sep. 30, 2019
EUR (€)
shares
Dec. 21, 2018
USD ($)
tranche
shares
Dec. 21, 2018
EUR (€)
tranche
€ / shares
shares
Summary of Investment Holdings [Line Items]                                    
Share price (Euro per share) | $ / shares                 $ 0.55                  
Investment | $           $ 5,753,000       $ 5,679,000                
Loss from investments | $           0 $ (64,000)                      
Cansativa | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares                                 3,096 3,096
Investments, fully diluted pre-money valuation                                   € 8,500,000
Preferred Shares | Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (Euro per share) | € / shares                     € 543.31              
Preferred Shares | Cansativa | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued, price per share (Euro per share) | € / shares                                   € 322.97
Cansativa                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held   7.60%                                
Gain (loss) on investments | $       $ 211,000   0                        
Sale of stock, number of shares issued/sold in transaction (in shares) | shares   1,586 1,586                              
Proceeds from sale of equity method investments     € 2,300,000                              
Gain (loss) on sale of equity method investments | $   $ 1,983,000                                
Additional gain (loss) on equity method investments | $   $ 4,868,000                                
Loss from investments | $           $ 0 $ 64,000                      
Cansativa | Cansativa, Employee Stock Ownership Plan (ESOP)                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares   992                                
Cansativa | Tranche One                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   € 1,000,000
Cansativa | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Investments, net                                   € 7,000,000
Number of investment tranches | tranche                                 3 3
Percentage of interest held                                 10.53% 10.53%
Payments to acquire investments € 3,100       € 996,820                          
Share price (Euro per share) | € / shares                                   € 1.00
Investment                                 $ 1,075,000 € 999,920
Investments, initial amount                                   3,100
Investments, capital reverse payment                                   996,820
Investments, additional                             $ 722,000 € 650,000    
Investments, additional, shares (in shares) | shares                             2,138 2,138    
Investments, consideration transferred, net assets                             16.60% 16.60%    
Net assets                               € 1,233,000    
Goodwill                               € 1,122,000    
Cansativa | Seed Financing Round | Cansativa, Employee Stock Ownership Plan (ESOP)                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held                       15.80% 16.59%          
Cansativa | Seed Financing Round | Tranche One                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                 $ 1,075,000 999,920
Cansativa | Seed Financing Round | Tranche Two                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                           € 0       3,000,000
Gain (loss) on investments | $               $ (370,000)                    
Cansativa | Seed Financing Round | Tranche Three                                    
Summary of Investment Holdings [Line Items]                                    
Investments, gross                                   € 3,000,000
Cansativa | Common Stock                                    
Summary of Investment Holdings [Line Items]                                    
Number of shares registered and fully paid-in capital (in shares) | shares                                 26,318 26,318
Cansativa | Preferred Shares | Series B Preferred Stock                                    
Summary of Investment Holdings [Line Items]                                    
Shares issued (in shares) | shares   10,184                                
Cansativa | Preferred Shares | Seed Financing Round                                    
Summary of Investment Holdings [Line Items]                                    
Percentage of interest held                     14.22% 15.80%